Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic profiling reveals novel insights into hypercortisolism adrenal adenomas.

Metabolism: clinical and experimental·2026
Same author

CXCR4 reduces aldosterone synthesis via regulating CYP11B2 expression.

Genes & diseases·2026
Same author

Lysine acetylome profiling reveals a dual regulatory role in carbon flux redirection and RNA degradation inhibition in <i>Mycobacterium smegmatis</i>.

Frontiers in microbiology·2026
Same author

Preclinical evaluation of a fluorinated bifendate derivative in triple-negative breast cancer: integrated in vitro and in vivo evidence of antitumor activity.

BMC cancer·2026
Same author

Endoscopic ultrasound-guided ethanol ablation for aldosterone-producing adenoma.

Endoscopy·2026
Same author

mRNALocator-imb: an imbalance-tolerant ensemble framework integrating random forest and transformer for mRNA subcellular localization prediction.

Frontiers in genetics·2026

Related Experiment Video

Updated: Apr 16, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.7K

Lipopolysaccharide-binding protein cannot independently predict type 2 diabetes mellitus: A nested case-control

Huang Zhou1, Jinbo Hu1, Qibo Zhu1

  • 1Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Journal of Diabetes
|March 11, 2015
PubMed
Summary

Serum lipopolysaccharide-binding protein (LBP) levels do not predict the risk of developing type 2 diabetes mellitus (T2DM). This longitudinal study found no association between baseline LBP and future T2DM development after adjusting for key factors.

Keywords:
diabetesendotoxinemialipopolysaccharide-binding proteinrisk内毒素血症糖尿病脂多糖结合蛋白风险

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

25.0K

Related Experiment Videos

Last Updated: Apr 16, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.7K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

25.0K

Area of Science:

  • Metabolic Disorders
  • Diabetes Mellitus Research
  • Biomarker Discovery

Background:

  • Cross-sectional studies suggest a link between serum lipopolysaccharide-binding protein (LBP) and metabolic disorders.
  • No prior longitudinal studies have investigated the association between LBP and type 2 diabetes mellitus (T2DM).

Purpose of the Study:

  • To investigate the association between serum LBP levels and the risk of developing T2DM in a prospective cohort.
  • To determine if LBP can serve as an independent predictor for T2DM development.

Main Methods:

  • A 5-year nested case-control study involving 3510 participants from the Environment, Inflammation and Metabolic Diseases Study (EIMDS).
  • Serum LBP, insulin, and high-sensitivity C-reactive protein levels were measured at baseline and after 5 years.
  • Type 2 diabetes mellitus (T2DM) diagnosis was based on oral glucose tolerance tests and established criteria; controls were matched for age, gender, and BMI.

Main Results:

  • Over 5 years, 255 participants developed T2DM.
  • No significant difference in baseline serum LBP levels was observed between T2DM cases and controls.
  • Analysis across LBP concentration tertiles revealed no significant association with T2DM risk, even after adjusting for covariates.

Conclusions:

  • Serum LBP levels do not independently predict the future development of type 2 diabetes mellitus (T2DM).
  • The findings suggest LBP is not a useful standalone biomarker for T2DM risk prediction in this population.